Is 2023 the Year for OTC Naloxone?
The FDA Law Blog
FEBRUARY 16, 2023
While laypeople are already using NNS in a number of states, FDA has cautioned that the current community use differs from OTC use because many of these programs provide patient counseling and instructions for use that go beyond what is included in the current NNS labeling. including a QR code that links to additional training).
Let's personalize your content